Fundies. English
Segment disclosures
Company overviewAEGLEA BIOTHERAPEUTICS, INC.
Each reported dimension combination stays separate. Revenue and operating income are shown as reported, with their dates and sources.
Revenue · Reported segment facts
1 dimension combinations 4 retained observations 4 reported periods
Counts describe retained dimensioned rows only. Periods and members can change across reports, and this view does not infer missing values or expected segment totals.
Operating Segments · Reportable Segment
Consolidation Items · Statement Business Segments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=syre:ReportableSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2025-01-01 – 2025-12-31 | 0 | USD | 20260219 | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 0 | USD | 20260219 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 886000 | USD | 20260219 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 2329000 | USD | 20250227 | Open filing evidence |